Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-172152
Filing Date
2014-04-30
Accepted
2014-04-30 16:17:41
Documents
5
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d716132ddefa14a.htm DEFA14A 22453
2 GRAPHIC g716132notice_pg01.jpg GRAPHIC 77196
3 GRAPHIC g716132notice_pg02.jpg GRAPHIC 123669
4 GRAPHIC g716132notice_pg03.jpg GRAPHIC 37818
5 GRAPHIC g716132notice_pg04.jpg GRAPHIC 8868
  Complete submission text file 0001193125-14-172152.txt   365366
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 14798976
SIC: 2834 Pharmaceutical Preparations